ReNeuron Group Plc has upgraded its collaboration with the Schepens Eye Research Institute in the US with the signing of a patent and licensing deal giving it rights to develop and commercialise human retinal precursor cells (hRPCs). ---Subscribe to MedNous to access this article--- Regenerative Medicine Company News Finance, Grants, Deals
